Why the study?
Thromboembolism complicating malignant tumors and chemotherapy has been increasing and gaining attention as cancer-associated thrombosis.
Minimally invasive thrombectomy and left ventricular reconstruction can be safely performed for a large mobile LV thrombus following chemotherapy, enabling the early resumption of cancer treatment.
Answers are grounded in this paper and cite their sources.
Minimally invasive thrombectomy may enable prompt chemotherapy resumption in select cancer patients with LV thrombus; leaves open need for prospective comparison with anticoagulation alone.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Shibata et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: